Antibodies as ideal therapeutic and diagnostic molecules are among the top-selling drugs
providing considerable efficacy in disease treatment, especially in cancer therapy …

The discovery of hybridoma technology, described by Kohler and Milstein in 1975, and the
resulting ability to generate monoclonal antibodies (mAbs) initiated a new era in antibody …

Monoclonal antibodies (mAbs) and their derivatives have achieved remarkable success as
medicine, targeting both diagnostic and therapeutic applications associated with …

Twenty years after its development, antibody phage display using filamentous
bacteriophage represents the most successful in vitro antibody selection technology. Initially …

For almost 15 years phage display is being used for the selection of specific antigen-binders
from artificial libraries of single chain antibodies. Filamentous phages have been developed …

Phage display technology has played a key role in the remarkable progress of discovering
and optimizing antibodies for diverse applications, particularly antibody-based drugs. This …

With major developments in molecular biology, numerous display technologies have been
successfully introduced for recombinant antibody production. Even so, phage display still …

Phage display has proven to be a robust and convenient technology for the selection of high-
quality human antibodies from diverse libraries. Besides enabling the identification of …

In recent years, the use of surface-display vectors for displaying polypeptides on the surface
of bacteriophage and bacteria, combined with in vitro selection technologies, has …

Monoclonal antibodies (mAbs) have become one of the most important classes of
biopharmaceutical products, and they continue to dominate the universe of …